1. Home
  2. AGIO vs ZD Comparison

AGIO vs ZD Comparison

Compare AGIO & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

N/A

Current Price

$30.98

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Ziff Davis Inc.

ZD

Ziff Davis Inc.

N/A

Current Price

$50.64

Market Cap

1.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
AGIO
ZD
Founded
2007
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2013
1999

Fundamental Metrics

Financial Performance
Metric
AGIO
ZD
Price
$30.98
$50.64
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$46.11
★ $63.33
AVG Volume (30 Days)
★ 1.2M
451.0K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 17.22
Revenue
$43,011,000.00
★ $1,364,028,000.00
Revenue This Year
$227.92
N/A
Revenue Next Year
$96.10
$0.79
P/E Ratio
★ N/A
$2.94
Revenue Growth
★ N/A
N/A
52 Week Low
$22.24
$22.45
52 Week High
$46.00
$60.48

Technical Indicators

Market Signals
Indicator
AGIO
ZD
Relative Strength Index (RSI) 44.24 36.40
Support Level $26.41 $39.78
Resistance Level $35.77 $56.43
Average True Range (ATR) 1.85 2.26
MACD -0.54 -0.71
Stochastic Oscillator 30.47 32.17

Price Performance

Historical Comparison
AGIO
ZD

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About ZD Ziff Davis Inc.

Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.

Share on Social Networks: